-
公开(公告)号：US20240350434A1
公开(公告)日：2024-10-24
申请号：US18760811
申请日：2024-07-01
Applicant: iX Biopharma Limited , iX Biopharma Ltd
Inventor： Yip Hang Eddy LEE , Chin Beng Stephen LIM
IPC: A61K31/135 , A61K9/00 , A61K47/36
CPC classification number: A61K31/135 , A61K9/006 , A61K47/36
Abstract: The invention concerns methods of using a ketamine dosage form in treating depression and, in particular, major depressive disorder and treatment-resistant depression, comprising administering to a patient in need thereof, a fast dissolving freeze-dried wafer solid dosage form with a matrix for rapid release and absorption of ketamine in the oral cavity of the said patient.
-
公开(公告)号：US20230210789A1
公开(公告)日：2023-07-06
申请号：US18000497
申请日：2021-05-28
Applicant: iX Biopharma Limited , iX Biopharma Ltd
Inventor： Yip Hang Eddy LEE , Chin Beng Stephen LIM
IPC: A61K31/135 , A61K47/36 , A61K9/00
CPC classification number: A61K31/135 , A61K47/36 , A61K9/006
Abstract: The invention concerns methods of using a ketamine dosage form in treating depression and, in particular, major depressive disorder and treatment-resistant depression, comprising administering to a patient in need thereof, a fast dissolving freeze-dried wafer solid dosage form with a matrix for rapid release and absorption of ketamine in the oral cavity of the said patient.
